Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.

Clark, Natasha M; Janaka, Sanath Kumar; Hartman, William; Stramer, Susan; Goodhue, Erin; Weiss, John; Evans, David T; Connor, Joseph P

Clark, Natasha M; Janaka, Sanath Kumar; Hartman, William; Stramer, Susan; Goodhue, Erin; Weiss, John; Evans, David T; Connor, Joseph P.

Affiliation

Clark NM; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
Janaka SK; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
Hartman W; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
Stramer S; American Red Cross, Washington, DC, United States of America.
Goodhue E; American Red Cross, Washington, DC, United States of America.
Weiss J; American Red Cross, Washington, DC, United States of America.
Evans DT; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
Connor JP; Wisconsin National Primate Research Center, Madison, Wisconsin, United States of America.

PLoS One ; 17(3): e0257930, 2022.

Article de En | MEDLINE | ID: mdl-35259162

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunoglobuline A / Immunoglobuline G / Glycoprotéine de spicule des coronavirus / COVID-19 Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google